Our results demonstrated a significantly higher frequency of heterozygous alleles (GC) in CRC patients compared to controls at rs3813865 in CYP2E1, indicating an association with CRC incidence (Table 1). This evidence concerns the gene CYP2E1 and colorectal carcinoma.